SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-17-301037
Filing Date
2017-10-02
Accepted
2017-10-02 16:35:49
Documents
40
Period of Report
2017-07-19
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d461901d8ka.htm 8-K/A 22288
2 EX-23.1 d461901dex231.htm EX-23.1 2107
3 EX-99.1 d461901dex991.htm EX-99.1 112088
4 EX-99.2 d461901dex992.htm EX-99.2 104997
5 EX-99.3 d461901dex993.htm EX-99.3 133886
12 GRAPHIC g461901g0923121827439.jpg GRAPHIC 3291
  Complete submission text file 0001193125-17-301037.txt   1710878

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dare-20170630.xml EX-101.INS 234845
7 XBRL TAXONOMY EXTENSION SCHEMA dare-20170630.xsd EX-101.SCH 23578
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dare-20170630_cal.xml EX-101.CAL 22934
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dare-20170630_def.xml EX-101.DEF 63918
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dare-20170630_lab.xml EX-101.LAB 178320
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dare-20170630_pre.xml EX-101.PRE 121948
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36395 | Film No.: 171114905
SIC: 2834 Pharmaceutical Preparations